Glaukos Corporation [GKOS] stock is trading at $106.91, down -0.65%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GKOS shares have gain 6.34% over the last week, with a monthly amount drifted -13.95%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Glaukos Corporation [NYSE: GKOS] stock has seen the most recent analyst activity on February 19, 2025, when Mizuho upgraded its rating to a Outperform and also boosted its price target to $200 from $140. Previously, Citigroup upgraded its rating to Buy on December 11, 2024, and elevated its price target to $162. On December 06, 2024, UBS initiated with a Buy rating and assigned a price target of $182 on the stock. Morgan Stanley downgraded its rating to a Underweight but stick to its price target of $120 on December 02, 2024. Citigroup downgraded its rating to a Neutral but $132 remained the price target by the analyst firm on July 10, 2024. Jefferies upgraded its rating to Buy for this stock on May 06, 2024, and upped its price target to $125. In a note dated December 21, 2023, JP Morgan upgraded an Overweight rating on this stock and boosted its target price from $66 to $91.
Glaukos Corporation [GKOS] stock has fluctuated between $87.59 and $163.71 over the past year. Currently, Wall Street analysts expect the stock to reach $152 within the next 12 months. Glaukos Corporation [NYSE: GKOS] shares were valued at $106.91 at the most recent close of the market. An investor can expect a potential return of 42.18% based on the average GKOS price forecast.
Analyzing the GKOS fundamentals
Glaukos Corporation [NYSE:GKOS] reported sales of 383.48M for the trailing twelve months, which represents a growth of 28.09%. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at -0.28%, Pretax Profit Margin comes in at -0.38%, and Net Profit Margin reading is -0.38%. To continue investigating profitability, this company’s Return on Assets is posted at -0.15, Equity is -0.23 and Total Capital is -0.12. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 105.66 points at the first support level, and at 104.40 for the second support level. However, for the 1st resistance point, the stock is sitting at 108.29, and for the 2nd resistance point, it is at 109.66.
Ratios To Look Out For
For context, Glaukos Corporation’s Current Ratio is 5.99. In addition, the Quick Ratio stands at 5.22 and the Cash Ratio stands at 2.26. Considering the valuation of this stock, the price to sales ratio is 15.77, the price to book ratio is 7.87.
Transactions by insiders
Recent insider trading involved Thurman Alex R., Officer, that happened on Mar 25 ’25 when 1520.0 shares were purchased. Director, Foley Mark J completed a deal on Feb 26 ’25 to sell 20687.0 shares. Meanwhile, Director Foley Mark J bought 20687.0 shares on Feb 26 ’25.
